Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Limbal epithelial stem cells (LESCs) and conjunctival goblet cells (CGCs) are essential cellular components that maintain the physiological integrity and transparency of the ocular surface. LESCs are located in the basal limbal epithelium and are responsible for the continuous regeneration of the corneal epithelium, acting as a barrier against the encroachment of the conjunctiva (Pellegrini et al., 2014, PubMed). Conjunctival goblet cells are specialized secretory cells that produce MUC5AC, a gel-forming mucin that stabilizes the tear film and protects the ocular surface from desiccation and pathogens (Gipson, 2016, PubMed). Dysfunction or depletion of these cells leads to severe ocular surface diseases, including limbal stem cell deficiency (LSCD) and dry eye disease, which can result in corneal scarring and vision loss (Dua et al., 2000, PubMed). While these are cell populations rather than single molecular targets, they are the focus of therapeutic interventions ranging from anti-inflammatory drugs like cyclosporine, which preserves goblet cell density, to regenerative medicine approaches such as autologous limbal epithelial cell transplantation (Pflugfelder, 2004, PubMed).
Drugs targeting these cell populations primarily function through anti-inflammatory pathways to preserve cell density, neurotrophic support to enhance stem cell survival, or cholinergic stimulation to induce mucin secretion.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Limbal epithelial stem cells and conjunctival goblet cells (LESC/CGC).